发明授权
US07501420B2 Composition and antiviral of substituted azaindoleoxoacetic piperazine derivatives
有权
取代的氮杂脱氧乙酸哌嗪衍生物的组成和抗病毒活性
- 专利标题： Composition and antiviral of substituted azaindoleoxoacetic piperazine derivatives
- 专利标题（中）： 取代的氮杂脱氧乙酸哌嗪衍生物的组成和抗病毒活性
-
申请号： US12015776申请日： 2008-01-17
-
公开(公告)号： US07501420B2公开(公告)日： 2009-03-10
- 发明人: Tao Wang , Zhongxing Zhang , Nicholas A. Meanwell , John F. Kadow , Zhiwei Yin , Qiufen May Xue , Alicia Regueiro-Ren , John D. Matiskella , Yasutsugu Ueda
- 申请人： Tao Wang , Zhongxing Zhang , Nicholas A. Meanwell , John F. Kadow , Zhiwei Yin , Qiufen May Xue , Alicia Regueiro-Ren , John D. Matiskella , Yasutsugu Ueda
- 申请人地址： US NJ Princeton
- 专利权人： Bristol-Myers Squibb Company
- 当前专利权人： Bristol-Myers Squibb Company
- 当前专利权人地址： US NJ Princeton
- 代理商 John F. Levis; Jennifer C. Chapman; Samuel J. DuBoff
- 主分类号： A61K31/437
- IPC分类号： A61K31/437
摘要：
This invention provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the invention is concerned with azaindoleoxoacetyl piperazine derivatives. These compounds possess unique antiviral activity, whether used alone or in combination with other antivirals, antiinfectives, immunomodulators or HIV entry inhibitors. More particularly, the present invention relates to the treatment of HIV and AIDS.
公开/授权文献
信息查询
IPC分类:
